Palisade Bio Inc
PALI
NASDAQ
Biotechnology
$2.14
USD
-0.01 (-0.47%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $368.58M
Volume 1.6M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals Inc | $404.63M | - | -71.3% | - | |
UPB | Upstream Bio Inc | $397.81M | - | +13.2% | - | |
FHTX | Foghorn Therapeutics Inc | $385.41M | - | +52.0% | - | |
PALI | Palisade Bio Inc | $368.58M | - | - | - | |
RCKT | Rocket Pharmaceuticals Inc | $368.29M | - | - | - | |
DMAC | DiaMedica Therapeutics Inc | $360.76M | - | - | - | |
IPSC | Century Therapeutics Inc | $348.08M | - | - | - | |
ZNTL | Zentalis Pharmaceuticals Inc | $316.55M | - | - | - |
Top Peer by Growth
Foghorn Therapeutics Inc
+52.0% YoY Revenue
Best 1-Year Return
Century Therapeutics Inc
+278.4% Return